HODGKIN LYMPHOMA, ADULT
Clinical trials for HODGKIN LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new HODGKIN LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for HODGKIN LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Low-Dose immunotherapy boost chemo for hodgkin lymphoma?
Disease control Recruiting nowThis phase 2 trial is testing whether adding a flat, low dose of the immunotherapy drug nivolumab to standard chemotherapy (AVD) can improve outcomes for adults with newly diagnosed advanced classic Hodgkin lymphoma. The study will enroll 54 participants and track how long they l…
Matched conditions: HODGKIN LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Survivors' hidden toll: chest radiation linked to brain changes
Knowledge-focused Recruiting nowThis study looks at Hodgkin lymphoma survivors who had chest radiation and bleomycin treatment as children. Researchers want to understand how these treatments affect blood flow to the brain and heart-lung function during exercise. About 100 survivors and healthy volunteers will …
Matched conditions: HODGKIN LYMPHOMA, ADULT
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC